RCS - Induction Healthcare - Induction AA rolls out new services nationwide

Induction HealthcareAnnouncement

06/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211206:nRSF5725Ua&default-theme=true

RNS Number : 5725U  Induction Healthcare Group PLC   06 December 2021

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Induction Attend Anywhere rolls out new services nationwide

 

Induction Healthcare (AIM: INHC), a leading healthcare technology company that
helps to digitally transform hospitals, announces that its remote consultation
service, Induction Attend Anywhere, has launched a key new healthcare
function. The platform, which has been rolled out across the UK, now also
supports clinical group consultations, where one-to-one consultations take
place within a group setting of patients with similar clinical conditions.

 

The pandemic, and related restrictions have impacted many group services
including addiction and mental health therapy provision. To date clinicians
offering digital group consultations have had to rely on non-clinical business
conferencing facilities to maintain some continuity, but these can come with
privacy and usability limitations.

 

Facing a backlog and an estimated 10 million people who may need new or
additional mental health support over the next three to five years (according
to the NHS Confederation), clinicians require a flexible care model which
enables remote group consultations at scale and within a clinically safe
setting.

 

Co-created with NHS providers, the Induction Attend Anywhere clinical group
consultations function has been designed to virtually mirror standard clinical
and patient workflow for optimum integration. A distinctive feature is that
there is a single-entry link for each clinical group consultation Waiting
Area, avoiding production of multi-patient links and helping to safeguard
clinician and patient confidentiality.

 

The new function leverages next generation patient entry and includes "in
call" features and controls that reduce clinical risk and prioritise privacy
and security. For example, only the service providers can see callers' names
and they have full control to admit, deny or remove individual participants.

 

Through Induction Attend Anywhere patients can be confident that the platform
is separate from their business or personal accounts, and that their
information is anonymised for all others participating in the remote clinical
consultation. This is particularly important for clinical group consultations
where confidentiality is paramount. Key features here ensure no digital
footprint is the left by patients and that the consultation room cannot be
re-joined to view any chat data.

 

The development of a clinical group consultations function offers immediate
support to the 300,000 health professionals who already use Induction Attend
Anywhere. More broadly, it provides another important tool to enable
community-based healthcare, a key aim of the NHS Long Term Plan.

 

James Balmain, CEO of Induction Healthcare said: "We are delighted to share
the expansion of our Induction Attend Anywhere platform, which enables the NHS
to integrate remote clinical group consultations within a secure and private
setting. This bespoke function will support the NHS to scale-up crucial
services like counselling to some of the hardest to reach patients. It will
help address the current backlog while transforming healthcare for the
longer-term."

 

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

 James Balmain, Chief Executive Officer

 Dr Hugo Stephenson, Group Executive Director

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Paul McManus / Alice Woodings                          Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) is a leading virtual care platform driving digital
transformation of healthcare systems worldwide. Induction solutions enhance
the investments hospitals have made and lay the foundation for their future.
Our products can enable information sharing between busy doctors, alleviate
operational burdens on hospitals or put patients in better control of their
care, all while ensuring the highest standards of clinical safety and
information security. We unchain staff and patients from the limitations of
paper-based and desktop systems, creating substantial time and cost
efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the
UK, Ireland, Australia and South Africa, as well as a rapidly growing number
of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK,
used by the majority of hospital doctors within the NHS. The app helps to
increase productivity and enhance communication by securely sharing phone
numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital
trusts within the NHS, with the ability to collaboratively create, edit, and
publish their own local medical guidelines in a secure and locally
administrated environment. This increases knowledge of, and adherence to,
guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting
hospitals. The platform allows patients to book and access their appointments,
read their clinical letters, store a copy of their clinical record and provide
data to their care teams remotely. It is not just a compelling patient
experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video
consultations. It helps hospitals, health systems and other customers offer
video consultations to patients and service users as a normal part of
day-to-day clinical activity. Our vision is for video consultations to improve
lives and help address social, access, equity and sustainability challenges by
allowing healthcare providers to determine how and when they see a patient
based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads
and writes patient demographic, appointment and clinical record data between a
growing number of hospital EHR systems and the Induction platforms. This
connectivity between stakeholders and legacy IT systems adds substantial value
to pre-existing health IT investment and allows large-scale adoption of
Induction app-based services.

 

 

About RNS Reach announcements

 

RNS Reach is an investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute media only /
non-regulatory news releases such as marketing messages, corporate and product
information into the public domain. An RNS Regulatory announcement is required
to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRABUBDDDXGDGBX